aod9604 dosing and frequency AOD 9604: Advanced Peptide Therapy for Effective Fat Loss AOD-9604, MOTs-C, Tesamorelin (Fat Burner)

Researchers considering this stack should start with conservative doses of each compound and monitor carefully for unexpected effects

Two practical points follow

In a 2001 study published in Endocrinology , Heffernan and colleagues reported that chronic AOD-9604 administration reduced body weight gain, decreased adipose tissue mass, and increased fat oxidation in obese mice without altering IGF-1 levels or glucose metabolism effects that were abolished in beta3 adrenergic receptor (3-AR) knockout mice, implicating 3-AR signaling as the mechanism of action [1]

In clinical use, significant side effects are uncommon, and the vast majority of patients tolerate the therapy without problems